Literature DB >> 21707937

Clinical course and molecular features in 21 patients with atypical chronic myeloid leukemia.

M Koldehoff, N K Steckel, Y Hegerfeldt, M Ditschkowski, D W Beelen, A H Elmaagacli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21707937     DOI： 10.1111/j.1751-553X.2011.01351.x

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN： 1751-5521            Impact factor:   2.877


× No keyword cloud information.
  7 in total

1.  Characteristics and survival of BCR/ABL negative chronic myeloid leukemia: a retrospective analysis of the Surveillance, Epidemiology and End Results database.

Authors:  Smith Giri; Ranjan Pathak; Mike G Martin; Vijaya Raj Bhatt
Journal:  Ther Adv Hematol       Date:  2015-12

2.  Routine blood examinations combined with morphological analysis for the diagnosis of myelodysplastic/myeloproliferative neoplasms.

Authors:  Huanling Wu; Hui Sun; Zhifen Zhang; Xiangli Li; Yuantang Li; Li Li; Rui Xu; Zie Wang; Wenjun Tian
Journal:  Oncol Lett       Date:  2016-09-21       Impact factor: 2.967

Review 3.  Treatment of MDS/MPN and the MDS/MPN IWG International Trial: ABNL MARRO.

Authors:  Andrew T Kuykendall; Eric Padron
Journal:  Curr Hematol Malig Rep       Date:  2019-12       Impact factor: 3.952

4.  Successful transplantation of ethnically mismatched cord blood in a boy with atypical chronic myeloid leukemia.

Authors:  Tang-Her Jaing; Iou-Jih Hung; Shih-Hsiang Chen; Wen-I Lee; Yu-Chuan Wen; En-Chen Fang
Journal:  Int J Hematol       Date:  2012-12-22       Impact factor: 2.490

5.  Characteristics and survival of patients with atypical chronic myeloid leukemia.

Authors:  Jee Hyun Kong; Hohyung Nam; Tae-Hwa Go; Shin Young Hyun; Kwang Yong Shim
Journal:  Blood Res       Date:  2019-09-25

Review 6.  Allogeneic Hematopoietic Stem Cell Transplantation for Mixed or Overlap Myelodysplastic/Myeloproliferative Disorders.

Authors:  Argiris Symeonidis; Spiros Chondropoulos; Evgenia Verigou; Vasileios Lazaris; Alexandra Kourakli; Panagiotis Tsirigotis
Journal:  Front Oncol       Date:  2022-08-05       Impact factor: 5.738

Review 7.  Atypical Chronic Myeloid Leukemia: Where Are We Now?

Authors:  Elena Crisà; Maura Nicolosi; Valentina Ferri; Chiara Favini; Gianluca Gaidano; Andrea Patriarca
Journal:  Int J Mol Sci       Date:  2020-09-18       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.